Table 3.
LC-Plasma uptake by mDCs stimulated with LC-Plasma mixed with emulsifiers.
| No. | Plasma | Emulsifier | % of FITC-positive cells | |
|---|---|---|---|---|
| 1 | − | − | 0.0 ± 0.0 | |
| 2 | + | − | 5.6 ± 0.1 | |
| 3 | + | P-1670 | 4.9 ± 0.2 | |
| 4 | + | S-1670 | 3.4 ± 0.1 | ** |
| 5 | + | M-1695 | 5.1 ± 1.2 | |
| 6 | + | TRP-97RF | 3.6 ± 0.3 | ** |
| 7 | + | S-28D | 5.9 ± 0.0 | |
| 8 | + | M-7D | 5.6 ± 0.2 | |
| 9 | + | L-100 | 7.1 ± 0.2 | * |
mDCs were cultured with 10 μg/mL of pHrodo™-conjugated LC-Plasma or 10 μg/mL of pHrodo™-conjugated LC-Plasma mixed with emulsifiers for 18 h. The cells were harvested and the percentage of cells that emitted fluorescence was determined by flow cytometry analysis. The data show the mean ± SD for triplicate wells. The statistical significance of differences among treatment groups was measured using one-way ANOVA with Dunnett’s post-hoc test for comparison to the LC-Plasma alone group (*p < 0.05, **p < 0.01).